Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Caris Life Sciences Inc (CAI)

Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,929,938
  • Shares Outstanding, K 254,403
  • Annual Sales, $ 294,010 K
  • Annual Income, $ 27,730 K
  • EBIT $ 0 M
  • EBITDA $ 0 M
  • 60-Month Beta N/A
  • Price/Sales 2.83
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm 0.00
  • Most Recent Earnings N/A on 11/05/21
  • Next Earnings Date 11/18/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical Services

Options Overview Details

View History
  • Implied Volatility 78.24% ( +0.32%)
  • Historical Volatility N/A
  • IV Percentile 23%
  • IV Rank 42.96%
  • IV High 82.93% on 07/07/25
  • IV Low 74.70% on 06/30/25
  • Put/Call Vol Ratio 0.20
  • Today's Volume 67
  • Volume Avg (30-Day) 122
  • Put/Call OI Ratio 0.46
  • Today's Open Interest 991
  • Open Int (30-Day) 574

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate 2.56
  • Number of Estimates 1
  • High Estimate 2.56
  • Low Estimate 2.56
  • Prior Year 1.76
  • Growth Rate Est. (year over year) +45.45%

Most Recent Stories

More News
From Retinal Scans to Cancer Genomics: Public AI Healthcare Plays You Shouldn’t Ignore

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – As populations age and chronic illnesses become more widespread, healthcare systems around the world are...

CAI.AX : 0.115 (+9.52%)
HCTI : 0.0239 (+19.50%)
AVAI : 0.5669 (+5.80%)
IRTC : 134.71 (+1.38%)
CAI : 26.62 (-2.28%)
CTEV : 47.62 (-4.65%)
Should You Buy Caris Life Sciences Stock After the CAI IPO?

Shares of the company are up almost 30% from its IPO price.

MRK : 84.02 (+0.37%)
CAI : 26.62 (-2.28%)
ABBV : 195.00 (+2.30%)
Alibaba Unveils Its Spin-Off Plans

Chinese e-commerce giant Alibaba Group Holdings Ltd. (NASDAQ: BABA) announced in November 2022 that it would be spinning off six companies. Ali Baba has b

BABA : 106.64 (+2.71%)
PDD : 104.97 (-0.03%)
INTC : 23.82 (+1.62%)
TCEHY : 63.1900 (-0.44%)
CAI : 26.62 (-2.28%)
JD : 31.22 (-1.20%)
AMZN : 222.26 (-0.13%)
High Grade Gold Intersected in First Drill Program at Talga Talga Gold Project

HIGHLIGHTS

NVO-WT.TO : 0.01 (unch)
NSRPF : 0.0763 (-0.91%)
NVO.TO : 0.1000 (-4.76%)
CAI : 26.62 (-2.28%)
CAI International, Inc. Stockholders Approve Merger Agreement for Acquisition by Mitsubishi HC Capital Inc.

CAI International, Inc. (NYSE: CAI) (“CAI” or the “Company”), one of the world’s leading transportation finance companies, announced today that the Company’s common stockholders, at a special...

CAI : 26.62 (-2.28%)
CAI International, Inc. Declares Quarterly Dividend

CAI International, Inc. (NYSE: CAI) (“CAI” or the “Company”), one of the world’s leading transportation finance companies, announced today that CAI’s Board of Directors declared a cash dividend...

CAI : 26.62 (-2.28%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates CLDB, CAI, SAFM, SBKK; Shareholders are Encouraged to Contact the Firm

NEW YORK, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:

SAFM : 204.00 (-2.51%)
CLDB : 29.15 (+3.81%)
SBKK : 18.5800 (+1.03%)
CAI : 26.62 (-2.28%)
CAI International, Inc. Announces Receipt by Subsidiary CAL Funding IV Limited of Requisite Consents in Consent Solicitation Relating to its 2.22% Fixed Rate Asset-Backed Notes, Series 2020-1, Class A

CAI International, Inc. (NYSE: CAI) (“CAI” or the “Company”), one of the world’s leading transportation finance companies, announced today that its subsidiary CAL Funding IV Limited (“CAL Funding”)...

CAI : 26.62 (-2.28%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates CORE, CAI, BOCH, ADXS; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / July 10, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Core-Mark Holding Company, Inc. (NASDAQ:CORE)concerning...

CORE : 45.65 (-0.76%)
ADXS : 0.1203 (unch)
CAI : 26.62 (-2.28%)
BOCH : 15.17 (-1.56%)
INVESTIGATION ALERT: Halper Sadeh LLP Investigates CAI, SYKE, UFS, ALTA; Shareholders are Encouraged to Contact the Firm

NEW YORK, NY / ACCESSWIRE / July 3, 2021 / Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: CAI International, Inc. (NYSE:CAI) concerning potential...

UFS : 55.49 (+0.02%)
ALTA : 44.16 (-1.25%)
SYKE : 54.00 (+0.04%)
CAI : 26.62 (-2.28%)

Business Summary

Caris Life Sciences Inc. provides diagnostics and anatomic pathology services. It develops an unbiased profiling platform for novel target identification, drug development and delivery, diagnostic and disease monitoring and precision medicine enabling aspects. Caris Life Sciences Inc. is based in Irving,...

See More

Key Turning Points

3rd Resistance Point 27.64
2nd Resistance Point 27.34
1st Resistance Point 26.98
Last Price 26.62
1st Support Level 26.32
2nd Support Level 26.01
3rd Support Level 25.65

See More

52-Week High 30.70
Fibonacci 61.8% 28.68
Fibonacci 50% 28.05
Fibonacci 38.2% 27.42
Last Price 26.62
52-Week Low 25.40

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar